U.S. Retail Distributors Stock News

NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

Did CrowdStrike’s (CRWD) Project QuiltWorks AI Security Push Just Redefine Its Investment Narrative?

In April 2026, CrowdStrike launched Project QuiltWorks, an industry-wide coalition with partners including Accenture, EY, IBM Cybersecurity Services, Kroll, OpenAI, and Anthropic, while also rolling out a Frontier AI Readiness and Resilience Service and extending its Falcon Cloud Detection and Response capabilities to Google Cloud and regional infrastructures. An interesting angle is how Project QuiltWorks and the new AI risk service use frontier AI models and CrowdStrike’s Falcon data to...
NYSE:ACN
NYSE:ACNIT

Does Accenture (ACN) Now Offer Value After A 38% One-Year Share Price Slide?

If you are wondering whether Accenture's current share price reflects its true worth, this overview will help you connect the recent share performance with what the valuation signals are saying. At a last close of US$180.26, the stock has seen a 5.2% decline over 7 days, an 8.8% decline over 30 days, a 30.7% decline year to date, and a 38.2% decline over the past year. Recent coverage has focused on how Accenture is positioned within IT services, with investors paying close attention to how...
NYSE:OGE
NYSE:OGEElectric Utilities

OGE Energy (OGE) Heads Into Q1 2026 With 6.6% EPS Growth Testing Bull Narratives

OGE Energy (OGE) heads into its Q1 2026 update with trailing 12 month revenue of about US$3.3b and basic EPS of US$2.33, against a backdrop of 6.6% year over year earnings growth. Over recent quarters, revenue ranged from US$725.8 million to US$1.0b, while quarterly basic EPS moved between roughly US$0.31 and US$1.15, giving investors a clear view of the company’s earnings cadence through 2024 and 2025. With a 14.4% net margin and a P/E of 20.8x sitting below both peer and industry averages,...
NYSE:WELL
NYSE:WELLHealth Care REITs

Welltower (WELL) Q1 FFO Volatility Challenges Bullish Growth Narratives

Welltower (WELL) has opened 2026 with Q1 revenue of US$3.4b and basic EPS of US$1.04, against a backdrop of trailing twelve month revenue of US$11.8b and EPS of US$2.07 alongside 30% earnings growth over the past year. Over recent periods the company has seen revenue move from US$8.0b in the year to Q4 2024 to US$11.8b in the latest twelve month window, while EPS shifted from US$1.58 to US$2.07 as earnings growth ran ahead of the broader US market in the provided data. With net profit margins...
NYSE:FSS
NYSE:FSSMachinery

Federal Signal (FSS) Earnings Growth And 11.3% Margin Test Bullish Narratives

Federal Signal (FSS) has just posted its latest numbers, with recent quarterly revenue of US$597.1 million, basic EPS of US$1.00 and trailing twelve month EPS of US$4.06 supporting year over year earnings growth of 14%. Over the past reported periods, revenue has moved from US$463.8 million in Q1 2025 to US$597.1 million in Q4 2025, while quarterly EPS has ranged from US$0.76 to US$1.18 across that stretch, alongside trailing twelve month net income of US$246.6 million. With earnings growth...
NYSE:TTI
NYSE:TTIEnergy Services

A Look At TETRA Technologies (TTI) Valuation After Strong Quarterly Earnings And Profit Growth

Earnings jump puts TETRA Technologies in focus TETRA Technologies (TTI) has drawn fresh attention after first quarter earnings, with revenue of US$156.25 million and net income of US$8.32 million, compared with US$4.05 million a year earlier. See our latest analysis for TETRA Technologies. At a share price of US$9.70, TETRA Technologies has seen a 15.61% 1 month share price return but a 16.09% 3 month share price decline, while the 1 year total shareholder return of 240.35% points to longer...
NasdaqGS:CENX
NasdaqGS:CENXMetals and Mining

A Look At Century Aluminum (CENX) Valuation After Norðurál Restart And Mt. Holly Capacity Expansion

Why the Norðurál restart and Mt. Holly expansion matter for Century Aluminum (CENX) Century Aluminum (CENX) has moved back into focus after restarting the second potline at its Norðurál smelter in Iceland ahead of schedule, alongside fresh hot metal output from its expanded Mt. Holly, South Carolina plant. See our latest analysis for Century Aluminum. The latest Norðurál restart and Mt. Holly expansion headlines come after a period of strong total shareholder returns, with a 44.04% year to...
NasdaqGS:ACGL
NasdaqGS:ACGLInsurance

Arch Capital Group (ACGL) Net Margin Strength Reinforces Bullish Profitability Narratives In Q1 2026

Arch Capital Group (ACGL) opened 2026 with Q1 revenue of US$4.5b and basic EPS of US$2.94, setting the tone for how investors read the latest set of numbers against an already profitable track record. Over recent periods the company has seen quarterly revenue move from US$4.5b in Q4 2024 to US$5.2b in Q2 2025 and US$4.7b in Q1 2025, with quarterly basic EPS ranging from US$1.51 to US$3.63 over the same stretch. Trailing 12 month EPS reached US$13.29. With trailing net margins at 24.4% and...
NYSE:RSI
NYSE:RSIHospitality

Rush Street Interactive (RSI) Q1 EPS Beat Tests Bullish Margin Expansion Narratives

Rush Street Interactive (RSI) opened 2026 with Q1 revenue of US$370.4 million and basic EPS of US$0.09, and on a trailing twelve month view it has generated US$1.2 billion of revenue and basic EPS of US$0.38 as investors weigh these results against a share price of US$27.98. The company has seen quarterly revenue move from US$262.4 million in Q1 2025 to US$370.4 million in Q1 2026, while basic EPS over the same quarters went from US$0.06 to US$0.09. This sets up a conversation around how much...
NYSE:VIRT
NYSE:VIRTCapital Markets

Virtu Financial (VIRT) Margin Strength Challenges Bearish Earnings Narratives

Virtu Financial (VIRT) has followed up its latest trailing twelve month performance with a Q1 2026 update set against a backdrop of US$2.8b in TTM revenue, TTM EPS of US$5.14, and a 68.1% jump in trailing earnings that coincides with a higher net profit margin of 15.4% versus 11.7% a year earlier. Over the last six reported quarters, revenue has moved from US$547.1 million in Q3 2024 to US$811.4 million in Q4 2025, while quarterly EPS has ranged between roughly US$0.65 and US$1.65. This gives...
NYSE:LII
NYSE:LIIBuilding

Lennox International (LII) Margin Stability Tests Bullish Narrative Of Future Expansion

Lennox International (LII) has entered Q1 2026 on the back of a year where quarterly revenue ranged from US$1.07b to US$1.50b in 2025 and basic EPS moved between US$3.39 and US$7.86, with trailing twelve month EPS at US$22.89 on revenue of US$5.20b. Over the past six reported quarters, revenue has shifted between US$1.07b and US$1.50b while quarterly basic EPS has stayed within a band of US$3.39 to US$7.86. This gives investors a clear view of how earnings scale with seasonal demand. With...
NYSE:PSN
NYSE:PSNProfessional Services

Parsons (PSN) Margin Stability At 3.8% Tests Bullish Earnings Growth Narrative

Parsons (PSN) has just opened 2026 earnings season with Q1 numbers that sit against a recent run of solid top line and bottom line figures, including Q4 2025 revenue of US$1.6b and basic EPS of US$0.52 on net income of US$55.6m. Over the past six reported quarters, revenue has ranged between US$1.6b and US$1.8b, while basic EPS has moved between US$0.51 and US$0.68. This gives investors a clear track record of how sales and earnings have translated into profit per share. With trailing net...
NYSE:OI
NYSE:OIPackaging

O-I Glass (OI) Q1 Loss Deepens Skepticism Around Bullish Margin Recovery Narrative

O-I Glass (OI) opened 2026 with Q1 revenue of US$1.5b and a basic EPS loss of US$0.48, while trailing twelve month revenue stood at US$6.4b alongside a TTM basic EPS loss of US$1.21. Over recent quarters, revenue has moved within a tight band from US$1.5b to US$1.7b, while quarterly basic EPS has swung between a profit of US$0.20 and a loss of US$1.00. As a result, the latest results keep the focus firmly on how quickly margins can improve from here. See our full analysis for O-I Glass. With...
NasdaqGS:FFIC
NasdaqGS:FFICBanks

Flushing Financial (FFIC) Net Interest Margin Stability Tests Bullish Growth Narratives

Flushing Financial (FFIC) opened Q1 2026 with trailing twelve month revenue of US$226.1 million and basic EPS of US$0.54, framing a return to profitability after prior losses that were shaped by a one off loss of US$17.6 million. Over recent quarters the company has seen quarterly revenue move between US$50.2 million and US$59.3 million, while basic EPS has ranged from a loss of US$1.63 per share to a profit of US$0.41 per share. This gives investors a clearer view of how earnings have reset...
NYSE:TWO
NYSE:TWOMortgage REITs

Two Harbors Investment (TWO) Returns To Quarterly Profit Challenging Bearish Narratives

Two Harbors Investment (TWO) opened 2026 with Q1 revenue of US$87.6 million and basic EPS of US$0.18, setting a cleaner starting point after a volatile run of quarterly results. The company has seen revenue move from US$7.9 million in Q1 2025 to US$87.6 million in Q1 2026, while quarterly EPS has swung from a loss of US$0.89 in early 2025 to a profit of US$0.18. This puts the latest numbers in sharp contrast to the weak trailing 12 month loss of US$3.77 per share. For investors, this mix of...
NYSE:ADM
NYSE:ADMFood

Is ADM’s Analyst Upgrades-Driven Outperformance Revealing a Durable Edge in Its Ingredients Strategy?

Archer-Daniels-Midland has recently outperformed the wider Consumer Staples sector, with analysts raising their earnings estimates as the company’s operations show relative strength versus both sector and Agriculture – Operations peers. This improved analyst sentiment highlights how ADM’s mix of agriculture processing and higher-margin ingredients is currently standing out within a typically defensive sector. We’ll now examine how ADM’s recent analyst upgrades and sector outperformance may...
NYSE:ALB
NYSE:ALBChemicals

Will a Smooth CFO-Side Transition and Rising Estimates Recast Albemarle's (ALB) Earnings Narrative?

Albemarle Corporation recently announced that long-serving Chief Accounting Officer Donald J. LaBauve Jr. will retire on June 1, 2026, after more than 36 years with the company, with the departure explicitly not tied to any disagreement over accounting or financial reporting. At the same time, Albemarle has drawn heightened investor attention as analysts have significantly raised near-term earnings estimates, reflecting a very large projected year-over-year increase in expected quarterly...
NYSE:RNST
NYSE:RNSTBanks

Renasant (RNST) Q1 EPS Strength Challenges Concerns Over Margin And Credit Pressures

Renasant (RNST) opened Q1 2026 with total revenue of US$265.8 million and basic EPS of US$0.94, alongside trailing twelve month revenue of US$978.3 million and EPS of US$2.41 that set the backdrop for the latest print. Over recent quarters, revenue has moved from US$165.9 million in Q1 2025 to US$265.8 million in Q1 2026, while quarterly EPS has ranged from US$0.01 in Q2 2025 to US$0.94 in the latest period, giving investors a clearer view of how profitability is flowing through the income...
NasdaqGS:ANIK
NasdaqGS:ANIKBiotechs

Anika Therapeutics (ANIK) Q4 Profit Challenges Ongoing Unprofitability Narrative Ahead Of Q1 Earnings

Anika Therapeutics (ANIK) closed Q4 2025 with total revenue of about US$30.6 million and basic EPS of US$0.13, setting the stage for Q1 2026 after a year in which trailing twelve month revenue reached roughly US$112.8 million and basic EPS on that basis was a loss of US$0.70. Over recent quarters the company has seen revenue move from US$26.2 million in Q1 2025 to US$30.6 million in Q4 2025, while basic EPS shifted from a loss of US$0.28 to a profit of US$0.13. This highlights a quarter that...
NYSE:BSX
NYSE:BSXMedical Equipment

Johnson And Johnson Trial Puts Boston Scientific Growth Story Under Scrutiny

Johnson & Johnson has launched a head to head clinical trial comparing its Varipulse Pro pulsed field ablation system with Boston Scientific's FARAPULSE platform. Boston Scientific's recent acquisition of Penumbra has raised questions around valuation, integration risks and potential pressure on its core pulsed field ablation business. Boston Scientific, NYSE:BSX, is in focus as competitive and deal related headlines converge on its core pulsed field ablation franchise. The shares trade at...
NYSE:TNC
NYSE:TNCMachinery

Slower Sales And Weaker Returns Might Change The Case For Investing In Tennant (TNC)

Tennant recently reported that customers postponing equipment purchases have contributed to a 1.6% annual revenue decline over the past two years, with earnings per share falling even faster and returns on capital weakening. This combination of softer demand and shrinking profitability per sale suggests the company is finding it harder to generate value from its existing operations. We’ll now examine how Tennant’s reduced earnings per share and returns on capital may reshape the company’s...
NasdaqCM:NEO
NasdaqCM:NEOHealthcare

NeoGenomics (NEO) Q1 Loss Of US$17.1 Million Tests Bullish Profitability Narratives

NeoGenomics (NEO) opened Q1 2026 with revenue of US$186.7 million, a basic EPS loss of US$0.13, and net income loss of US$17.1 million, setting a clear tone for how the year is starting after recent quarters of negative earnings. Over recent periods, the company has seen quarterly revenue move from US$172 million in Q4 2024 to US$168.0 million in Q1 2025 and US$181.3 million in Q2 2025, while quarterly EPS has remained in loss territory across the same stretch. The latest print therefore...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Ionis Pharmaceuticals (IONS) Trailing US$381.4m Loss Tests Bullish Profitability Narratives Ahead Of Q1 2026

Ionis Pharmaceuticals (IONS) opened 2026 with Q1 results that keep the focus firmly on its path to profitability, following 2025 figures that included Q4 revenue of US$203.3 million, a basic EPS loss of US$1.42, and a full year of trailing twelve month revenue of US$943.7 million against a net loss of US$381.4 million. Over recent quarters, the company has seen revenue move from US$131.6 million in Q1 2025 to US$452.0 million in Q2 2025, US$156.7 million in Q3 2025, and US$203.3 million in Q4...
NYSE:IEX
NYSE:IEXMachinery

Idex (IEX) Margin Slip To 14% Tests Bullish Growth Narrative

IDEX (IEX) just turned in its Q1 2026 scorecard, with recent quarterly revenue moving from US$798.2 million in Q3 2024 to US$899.1 million in Q4 2025. Over the same stretch, basic EPS ranged from US$1.26 in Q1 2025 to around US$1.74 in Q2 2025. During this period, trailing twelve month revenue was about US$3.5 billion at Q4 2025, with basic EPS of US$6.42. This gives investors a clearer view of how top line scale and per share earnings have been tracking ahead of this latest update and...